Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Genomic Announces Executive Appointments

Genomic Health, Inc. (Genomic) has appointed Kimberly J. Popovits as its president and chief executive officer (CEO). Prior to this, Popovits was president and chief operating officer (COO) of the company. He joined Genomic in February 2002 and as a director since March 2002. Earlier, Popovits served in various roles at Genentech, Inc. Genomic has appointed G. Bradley Cole as COO and will continue to serve as the company's chief financial officer (CFO). He reports to Popovits.

Most recently, Popovits served as as senior vice president, marketing and sales. She holds a B.A. in business from Michigan State University.

Cole comes to Genomic in 2004 as executive vice president and chief financial officer and was named executive vice president, operations, and CFO in January 2008. Earlier, Cole served in various senior management roles at Guidant Corporation and Applied Biosystems Incorporated. Cole holds a B.S. in business from Biola University and an M.B.A. from San Jose State University.

“Kim’s appointment as CEO reflects her unique experience and passion to lead all aspects of our business, as I turn my focus to the longer-term strategy and vision of the organization. This transition marks an important milestone for the company, reflecting our leadership and success in delivering personalized medicine to patients,” said Randy Scott, chairman of Genomic Health. “Brad’s increasing responsibility as COO recognizes his contribution to the operations of the company and further strengthens our ability to deliver our services to physicians and patients around the world. I look forward to working with Kim, Brad and our entire management team as we continue our efforts to expand worldwide commercialization of the Oncotype DX breast cancer assay, advance our research and development pipeline, and move the organization toward profitability.”

In addition to Scott, Popovits and Cole, members of the Genomic Health management team include Steve Shak, chief medical officer; Joffre Baker, chief scientific officer; David Logan, senior vice president of worldwide commercialization; Tricia Tomlinson, senior vice president of human resources; and Laura Leber, vice president of corporate communications.